Trademark Overview
On Sunday, July 12, 2026, a trademark application was filed for ORGANAGE with the United States Patent and Trademark Office. The USPTO has given the ORGANAGE trademark a serial number of 99935343. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Sunday, July 12, 2026. This trademark is owned by Cosmica, Inc.. The ORGANAGE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services, namely, medical testing and therapy in the field of aging, mortality risk, and disease risk; Laboratory testing and analysis for medical purposes, namely, biological system analysis using proteomics, epigenomics, transcriptomics, and metabolomics; Providing aging, mortality and disease risk for individuals, patients of clinics, outpatient services, health tech companies, and hospital systems; Anti-aging medical therapy; Medical services, namely, diagnostics for aging therapy; Medical services, namely, metabolic assessments to determine personalized supplement and nutritional intake tailored to individual longevity goals; Medical services, namely, metabolic testing; Providing personalized healthcare and medical information in the nature of anti-aging protocols for individuals; Genetic testing for medical purposes; Blood analysis services for diagnostic purposes provided by medical laboratories; Medical laboratory analysis services relating to the treatment of persons
Technology advisory services providing reports for personalized intake protocols tailored to individual longevity goals; Scientific and technological services, namely, laboratory analysis in the field of aging, mortality risk, and disease risk; Software as a service (SAAS) services featuring software used by businesses for analyzing their laboratory patient data; SAAS for analyzing laboratory patient data for biomarkers of mortality and disease risk; SAAS for analyzing patient laboratory data and test panels for risks classified within the international classification of disease (IDC); SAAS for analyzing medical data for patient aging rates and biological decline; SAAS featuring artificial intelligence analysis of medical data and patient biomarkers; Pharmaceutical research and development; Scientific study and research in the fields of anti-aging products, interventions, and procedures; Medical research information in the field of pharmaceuticals and anti-aging treatments
